Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)
NCT ID: NCT02887729
Last Updated: 2016-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Testing in Autosomal Dominant Polycystic Kidney Disease
NCT06085807
ADPKD Cohort Study
NCT02084849
Analysis of Patients With Autosomal Dominant Polycystic Kidney
NCT06759142
ADPKD Patient Registry
NCT04039061
Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease
NCT06036992
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>17
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannick Le Meur, MD PhD
Role: STUDY_DIRECTOR
University Hospital, Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AUB Brest
Brest, France, France
ECHO dialyse
Le Mans, France, France
CH Niort
Niort, France, France
ECHO Confluent
Rezé, France, France
CH de Saint Nazaire
Saint-Nazaire, France, France
CH Saint Malo
St-Malo, France, France
CHU Angers
Angers, , France
CHU Brest
Brest, , France
Centre Nephrologie et Dialyse d Armorique
Brest, , France
CH La Roche Sur Yon
La Roche-sur-Yon, , France
CH Le Mans
Le Mans, , France
AUB Lorient
Lorient, , France
CH Bretagne Sud
Lorient, , France
AUB Morlaix
Morlaix, , France
CHU Nantes
Nantes, , France
CHU Poitiers
Poitiers, , France
CH Centre Bretagne
Pontivy, , France
AUB Quimper
Quimper, , France
CHI de Cournouaille
Quimper, , France
CHU Rennes
Rennes, , France
Centre Heliomarin de Roscoff
Roscoff, , France
CH Yves LE FOLL
Saint-Brieuc, , France
ECHO Centre Ambulatoire
Saint-Herblain, , France
CHU Tours
Tours, , France
CH Bretagne Atlantique
Vannes, , France
ECHO Vannes
Vannes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Marie-Paule GUILLODO-HAMELET
Role: primary
Delphine LABATUT, PH
Role: primary
Dominique Besnier, MD
Role: primary
Eric Renaudineau, MD
Role: primary
Didier Legrand, MD
Role: primary
Maryvonne Hourmand, MD PhD
Role: primary
Corneliu Savoiu, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GENKYST
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.